Necrobiotic panniculitis due to repeated insulin injection: a rare cause of a false positive somatostatin receptor scintigraphy

• References

• 1 Balon HR, Goldsmith SJ, Siegel BA. et al. Procedure guideline for somatostatin receptor scintigraphy with ¹¹¹In-pentetreotide. J Nucl Med 2001; 42: 1134-8.
• 2 Degirmenci B, Bekis R, Sen M. et al. Indium-111 octreotide uptake in the surgical scar. Nuklearmedizin 1999; 38: 306-8.
• 3 Forster GJ, Krummenauer F, Nickel O. et al. Somatostatin- receptor scintigraphy in Graves’ disease: reproducibility and variance of orbital activity. Cancer Biother Radiopharm 2000; 15: 517-25.
• 4 Kainberger F, Kurtaran A, Kienast O. et al. Hybrid imaging for endocrine diseases: new perspectives. Wien Klin Wochenschr 2003; 115 (Suppl. 02) 87-90.
• 5 Ozer S, Dobrozemsky G, Kienast O. et al. Value of combined XCT/SPECT technology for avoiding false positive planar ¹²³I-MIBG scintigraphy. Nuklearmedizin 2004; 43: 164-70.
• 6 Reubi JC, Kvols E, Krenning E. et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 9: 78-81.
• 7 Virgolini I, Traub T, Novotny C. et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 2002; 8: 1781-807.